SCHEMBL8939190

SCHEMBL8939190

CC(C)OCCC(=O)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.44
KDM4E B2RXH2 3/20 0.40
GAA P10253 2/20 0.40
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
CHRM3 P20309 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
GRIN2D O15399 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
OPRM1 P35372 2/20 0.38
KCNH2 Q12809 2/20 0.38
CACNA1F O60840 1/20 0.38
ABCB1 P08183 1/20 0.38
CYP2B6 P20813 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8939171 0.83 KCNN4 (0.47) KCNN4KDM4EGAACHRM2CHRM1
SCHEMBL8939163 0.77 KCNN4 (0.44) KCNN4KDM4ECHRM2CHRM1CHRM3
SCHEMBL14685309 0.74 L3MBTL1 (0.52) KDM4EGAATSHRALDH1A1LMNA
SCHEMBL8880188 0.73 OPRM1 (0.41) KCNN4KDM4ECHRM2CHRM1CHRM3
SCHEMBL8939167 0.73 KCNN4 (0.47) KCNN4KDM4ECHRM2CHRM1CHRM3
SCHEMBL1405227 0.71 TSHR (0.54) KDM4EGAATSHRALDH1A1LMNA
SCHEMBL13828216 0.70 OPRM1 (0.55) KCNN4CHRM2CHRM1CHRM3CYP1A2
SCHEMBL13868873 0.70 KCNN4 (0.47) KCNN4CYP1A2OPRM1DRD3TSHR
SCHEMBL8939182 0.70 KCNN4 (0.44) KCNN4GRIN2DGRIN1GRIN2AGRIN2B
SCHEMBL9065615 0.70 CYP1A2 (0.61) KDM4ECYP2D6CYP1A2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5532228-A ANTITUMOR, PSORIASIS SCHERING AKTIENGESELLSCHAFT (DE) 1996-07-02 US disclosed